GH1 and Parkinson disease: The upregulated pathways comparing 20K hGH‐V to hGH include metabolic pathways such as the citrate (TCA) cycle (0.600 enrichment score [ES]), adipose tissue‐specific pathways such as adipogenesis (0.502 ES) and thermogenesis (0.402 ES), and neurodegenerative disease pathways such as Parkinson's disease (0.354 ES).